prikaz prve stranice dokumenta The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
  Preuzmi
PDF 523.29 KB
Znanstveni rad - Pregledni rad
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
Croatian medical journal, 63 (2022); 287-294. urn:nbn:hr:184:546698
Roguljić, Hrvoje; Arambašić, Jerko; Ninčević, Vjera; Kuna, Lucija; Šesto, Igor; Tabll, Ashraf; Smolić, Robert; Včev, Aleksandar; Primorac, Dragan; Wu, George; Smolić, Martina

Povezani objekti
COVID-19 (zbirka 2.) | Virtualna zbirka
Citirajte ovaj rad

Roguljić, H., Arambašić, J., Ninčević, V., Kuna, L., Šesto, I., Tabll, A. ... Smolić, M. (2022). The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?. Croatian medical journal, 63., 287-294. Preuzeto s https://urn.nsk.hr/urn:nbn:hr:184:546698

Roguljić, Hrvoje, et al. "The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?." Croatian medical journal, vol. 63, 2022, str. 287-294. https://urn.nsk.hr/urn:nbn:hr:184:546698

Roguljić, Hrvoje, Jerko Arambašić, Vjera Ninčević, Lucija Kuna, Igor Šesto, Ashraf Tabll, Robert Smolić, et al. "The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?." Croatian medical journal 63 (2022): 287-294. https://urn.nsk.hr/urn:nbn:hr:184:546698

Roguljić, H., et al. (2022) 'The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?', Croatian medical journal, 63, str. 287-294. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:184:546698 (Datum pristupa: 13.11.2024.)

Roguljić H, Arambašić J, Ninčević V, Kuna L, Šesto I, Tabll A, i sur.. The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?. Croatian medical journal [Internet]. 2022. [pristupljeno 13.11.2024.];63:287-294. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:546698

H. Roguljić, et al., "The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?", Croatian medical journal, vol. 63, str. 287-294, 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:546698. [Citirano: 13.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:546698
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
AutorHrvoje Roguljić
AutorJerko Arambašić
AutorVjera Ninčević
AutorLucija Kuna
AutorIgor Šesto
AutorAshraf Tabll
AutorRobert Smolić
AutorAleksandar Včev
AutorDragan Primorac
AutorGeorge Wu
AutorMartina Smolić
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za medicinsku biologiju i genetiku)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Infektologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
In patients with COVID-19, thromboinflammation is one of the main causes of morbidity and mortality, which makes anticoagulation an integral part of treatment. However, pharmacodynamic and pharmacokinetic properties of direct oral anticoagulants (DOACs) limit the use of this class of anticoagulants in COVID-19 patients due to a significant interference with antiviral agents. DOACs use in COVID-19 hospitalized patients is currently not recommended. Furthermore, patients already on oral anticoagulant drugs should be switched to heparin at hospital admission. Nevertheless, outpatients with a confirmed diagnosis of COVID-19 are recommended to continue prior DOAC therapy. More studies are required to clarify the pathogenesis of COVID-19-induced derangement of the coagulation system in order to recommend an appropriate anticoagulant treatment.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCroatian medical journal
Brojčani podacivol. 63, str. 287-294
p-ISSN0353-9504
URN:NBNurn:nbn:hr:184:546698
Datum objave publikacije2022
URL dokumentahttp://bib.irb.hr/1205752
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-08-12 11:42:37